• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Brand Quest
• The New Manager
• BL Club
• Smartbuy
• Books
• Gallery

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth
• Events 2007

Group Sites

• The Hindu
• The Hindu ePaper
• Business Line
• Business Line ePaper
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

Bangalore, Sept. 25 Strides Arcolab Ltd has said it had begun retail sale of its anti-influenza A/ H1N1 drug Starflu.

It would be available in the 480 designated drug stores that have the licence to sell Schedule X or restricted-sale drugs. Strides has priced it Rs 460 a strip of 10 capsules of 75 mg each. Starflu is the generic version of the drug oseltamivir marketed by Swiss pharma major Roche.

Mr Nitin Ghadiyar, President – Strides Arcolab Ltd, said, “Strides has the requisite stocks of Starflu to adequately supply and service the retail demand for this drug.”

It is marketing Starflu through its Domestic Critical Care Division. This is in addition to the government supplies for which Strides has bid, and exports, Mr Ghadiyar said. The Bangalore-based company is one of the five domestic companies licensed to make restricted retail sale to treat A/H1N1 or `swine flu’ besides Roche.

The pandemic has claimed over 260 lives in the country.

More Stories on : Announcements | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Copyright © 2009, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line